Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
CA 2414352 A1 · Owner: Wood, Ralph E. · Inventors: Wood, Ralph E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating a patient suffering from peripheral vascular disease peripheral neuropathies, or autonomic neuropathies by administering a cGMP PDE5 inhibitor such as sildenafil. The method is particularly applicable to patients suffering from diabetic foot ulcers Raynaud's Phenomenon, CREST , Syndrome erythromatosis, rheumatoid diseases, diabetic retinopathies and onychiomycosis. According to the present invention a cGMP PDE5 inhibitor may , be administered as a prophylactic to patients predisposed to develop a peripheral vascular disease, peripheral neuropathy or autonomic neuropathy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.